Cargando…
Universal vaccine against respiratory syncytial virus A and B subtypes
Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection in infants, young children, and the elderly. Two subtypes of RSV, A and B, circulate alternately at 1-2-year intervals during epidemics. The attachment glycoprotein (G protein) of RSV is one of the major ta...
Autores principales: | Lee, Jeong-Yoon, Chang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383302/ https://www.ncbi.nlm.nih.gov/pubmed/28384263 http://dx.doi.org/10.1371/journal.pone.0175384 |
Ejemplares similares
-
Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011) -
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
por: Kim, Joo Young, et al.
Publicado: (2016) -
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
por: Lee, Hyo-Jeong, et al.
Publicado: (2017) -
Need for a safe vaccine against respiratory syncytial virus infection
por: Kim, Joo-Young, et al.
Publicado: (2012) -
Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea
por: Jang, Ji-Eun, et al.
Publicado: (2011)